Head of Specialty Therapeutics

This is a fully remote position, open to applicants in Arizona, +6 more states.

📋 Description

• Act as the clinical expert on neuromodulation and new pharmacotherapies, including esketamine, ketamine, and therapies assisted by psychedelics.

• Develop and execute a comprehensive interventional psychiatry strategy that includes TMS, new pharmacotherapies, and neuromodulation techniques.

• Lead the creation of clinical programs for psychedelic-assisted therapies, such as psilocybin, MDMA, and other novel agents, in accordance with FDA guidelines and DEA regulations.

• Assess new specialty treatments by considering evidence, regulations, safety, operational viability, and patient requirements.

• Review and consolidate recent interventional psychiatry literature to guide strategy and competitive positioning.

• Create clinical protocols, eligibility criteria, care pathways, quality benchmarks, and safety monitoring protocols.

• Supervise the execution, performance assessment, and ongoing enhancement of specialty therapeutic services.

• Manage clinician training and credentialing standards, incorporating structured psychotherapy integration.

• Collaborate with Medical Leadership, Clinical Operations, Quality, Research, Finance, Legal, Compliance, and Operations teams.

• Navigate DEA Schedule I licensing, REMS mandates, and variations in state-level regulations.

• Work together on data gathering and frameworks for measuring outcomes.

• Track outcomes, adverse events, utilization trends, patient satisfaction, and effectiveness metrics.

• Cultivate partnerships with academic institutions, research organizations, specialty therapy centers, and external experts.

• Independently steer specialty therapeutic strategies, clinical standards, program design, and recommendations for outcome measurement.

• Provide leadership to clinical workgroups, specialty program teams, and cross-functional implementation collaborators.

⛳️ Requirements

• MD or DO with board certification in Psychiatry.

• Active, unrestricted medical license and ability to uphold necessary licensure standards.

• Over 10 years of clinical experience in psychiatry, including exposure to specialty, interventional, or advanced psychiatric treatment modalities.

• Proven capability to create clinical protocols, care pathways, safety standards, training frameworks, or program governance structures.

• Strong knowledge of clinical evidence review, patient safety, risk management, regulatory issues, and standards of care for specialty therapeutics.

• Ability to influence clinical and operational leaders across a complex, matrixed organization.

• Exceptional written, verbal, facilitation, and executive communication skills.

• Legally authorized to work in the United States.

• Awareness, inclusivity, sensitivity, humility, and experience working with individuals from diverse ethnic backgrounds, socioeconomic statuses, sexual orientations, gender identities, and other aspects of culture.

• Capacity to sit, stand, bend, talk, hear, and walk; ability to lift and/or move objects up to 25 pounds.

• Close vision, distance vision, color vision, peripheral vision, depth perception, and ability to adjust focus.

• Preferred: experience in developing, leading, or scaling specialty psychiatric treatment programs such as TMS, ketamine/esketamine, or other advanced therapy modalities.

• Preferred: background in clinical research, evidence generation, or outcomes evaluation.

• Preferred: experience in large multi-site, multi-state, or enterprise healthcare organizations.

• Preferred: collaboration experience with academic, research, vendor, or specialty treatment organizations.

🏝️ Benefits

• Competitive bonus plan.

• Equity potential.

• Reasonable accommodations for applicants and employees with disabilities.